Sana Biotechnology SANA Return on equity

Return on equity at other companies

Bristol-Myers SquibbBMY

46.7%+17.8pp

Vertex PharmaceuticalsVRTX

23.5%—

Gilead SciencesGILD

-20.6%-53.8pp

CRISPR TherapeuticsCRSP

-31.2%+43.7pp

Allogene TherapeuticsALLO

-52.3%-5.7pp

Ginkgo BioworksDNA

-56.3%+23.1pp

FAQ

What is Sana Biotechnology's return on equity?

Sana Biotechnology (SANA) reported return on equity of -147.4% in Q1 2026.

How has Sana Biotechnology's return on equity changed year-over-year?

Sana Biotechnology's return on equity decreased by 106.4% year-over-year, from -71.4% to -147.4%.

What is the long-term trend for Sana Biotechnology's return on equity?

Over 3 years (2022 to 2025), Sana Biotechnology's return on equity has grown at a 39.3% compound annual growth rate (CAGR), from -43.9% to -118.7%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.